Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study.

MLA

Dikranian, Ara H., et al. “Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study.” Rheumatology and Therapy, vol. 4, no. 2, Dec. 2017, pp. 363–74. EBSCOhost, https://doi.org/10.1007/s40744-017-0075-1.

APA

Dikranian, A. H., Mallay, R., Marshall, M., Francis-Sedlak, M., & Holt, R. J. (2017). Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study. Rheumatology and Therapy, 4(2), 363–374. https://doi.org/10.1007/s40744-017-0075-1

Chicago

Dikranian, Ara H, Rubaiya Mallay, Mike Marshall, Megan Francis-Sedlak, and Robert J Holt. 2017. “Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study.” Rheumatology and Therapy 4 (2): 363–74. doi:10.1007/s40744-017-0075-1.